Activation of vascular endothelial growth factor receptor-2 in bone marrow leads to accumulation of myeloid cells: Role of granulocyte-macrophage colony-stimulating factor

Journal of Immunology

Volumn 175, Issue 5, 2005, Pages 3015-3024

  Larrivée, Bruno ^a,b   Pollet, Ingrid ^b   Karsan, Aly ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYBRID PROTEIN; NEUTRALIZING ANTIBODY; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CLONOGENESIS; CONTROLLED STUDY; DIMERIZATION; HEMATOPOIESIS; MOUSE; MYELOID PROGENITOR CELL; MYELOPOIESIS; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

EID: 23844515056     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.5.3015     Document Type: Article

References (72)

1. Koch, A. E., L. A. Harlow, G. K. Haines, E. P. Amento, E. N. Unemori, W. L. Wong, R. M. Pope, and N, Ferrara. 1994. Vascular endothelial growth factor: a cytokine modulating endothelial function in rheumatoid arthritis. J. Immunol 152: 4149-4156.
2. Dvorak, H. F., L. F. Brown, M. Detmar, and A. M. Dvorak. 1995. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol 146: 1029-1039.
3. Ferrara, N., K. Carver-Moore, H. Chen, M. Dowd, L. Lu, K. S. O'Shea, L. Powell-Braxton, K. J. Hilian, and M. W. Moore. 1996. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380: 439-442.
4. Carmeliet, P., V. Ferreira, G. Breier, S. Pollefeyt, L. Kieckens, M. Gertsenstein, M. Fahrig, A. Vandenhoeck, K. Harpal, C. Eberhardt, et al. 1996. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380: 435-439.
5. Bautz, F., S. Rafii, L. Kanz, and R. Mohle. 2000. Expression and secretion of vascular endothelial growth factor-A by cytokine-stimulated hematopoietic progenitor cells: possible role in the hematopoietic microenvironment. Exp. Hematol. 28: 700-706.
6. Dikov, M. M., T. Oyama, P. Cheng, T. Takahashi, K. Takahashi, T. Sepetavec, B. Edwards, Y. Adachi, S. Nadaf, T. Daniel, et al. 2001. Vascular endothelial growth factor effects on nuclear factor-κB activation in hematopoietic progenitor cells. Cancer Res. 61: 2015-2021.
7. Gabrilovich, D., T. Ishida, T. Oyama, S. Ran, V. Kravtsov, S. Nadaf, and D. P. Carbone. 1998. Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood 92: 4150-4166.
8. Gerber, H. P., A. K. Malik, G. P. Solar, D. Sherman, X. H. Liang, G. Meng, K. Hong, J. C. Marsters, and N. Ferrara. 2002. VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature 417: 954-958.
9. Shalaby, F., J. Rossant, T. P. Yamaguchi, M. Gertsenstein, X. F. Wu, M. L. Breitman, and A. C. Schuh. 1995. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376: 62-66.
10. Hidaka, M., W. L. Stanford, and A. Bernstein. 1999. Conditional requirement for the Flk-1 receptor in the in vitro generation of early hematopoietic cells. Proc. Natl. Acad. Sci. USA 96: 7370-7375.
11. -/- embryonic stem cells and embryos. Proc. Natl. Acad. Sci. USA 96: 2159-2164.
12. Shalaby, F., J. Ho, W. L. Stanford, K. D. Fischer, A. C. Schuh, L, Schwartz, A. Bernstein, and J. Rossant. 1997. A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell 89: 981-990.
13. Ziegler, B. L., M. Valtieri, G. A. Porada, R. De Maria, R. Muller, B. Masella, M. Gabbianelli, I. Casella, E. Pelosi, T. Bock, et al. 1999. KDR receptor: a key marker defining hematopoietic stem cells. Science 285: 1553-1558.
14. Haruta, H., Y. Nagata, and K. Todokoro. 2001. Role of Flk-1 in mouse hematopoietic stem cells. FEBS Lett. 507: 45-48.
15. Padro, T., R. Bieker, S. Ruiz, M. Steins, S. Retzlaff, H. Burger, T. Buchner, T. Kessler, F. Herrera, J. Kienast, et al. 2002. Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia. Leukemia 16: 1302-1310.
16. Verstovsek, S., E. Estey, T. Manshouri, F. J. Giles, J. Cortes, M. Beran, A. Rogers, M. Keating, H. Kantarjian, and M. Albitar. 2002. Clinical relevance of vascular endothelial growth factor receptors 1 and 2 in acute myeloid leukemia and myelodysplastic syndrome. Br. J. Haematol. 118: 151-156.
17. LeCouter, J., C. Zlot, M. Tejada, F. Peale, and N. Ferrara. 2004. Bv8 and endocrine gland-derived vascular endothelial growth factor stimulate hematopoiesis and hematopoietic cell mobilization. Proc. Natl. Acad. Sci. USA 101: 16813-16818.
18. Yang, Z. F., R. T. Poon, Y. Luo, C. K. Cheung, D. W. Ho, C. M. Lo, and S. T. Fan. 2004, Up-regulation of vascular endothelial growth factor (VEGF) in small-for-size liver grafts enhances macrophage activities through VEGF receptor 2-dependent pathway. J. Immunol. 173: 2507-2515.
19. Larrivee, B., D. R. Lane, I. Pollet, P. L. Olive, R. K. Humphries, and A. Karsan. 2003. Vascular endothelial growth factor receptor-2 induces survival of hematopoietic progenitor cells. J. Biol. Chem. 278: 22006-22013.
20. Dranoff, G., A. D. Crawford, M. Sadelain, B. Ream, A. Rashid, R. T. Bronson, G. R. Dickersin, C. J. Bachurski, E. L. Mark, J. A. Whitsett, et al. 1994. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 264: 713-716.
21. Gerber, H. P., and N. Ferrara. 2003. The role of VEGF in normal and neoplastic hematopoiesis. J. Mol. Med. 81: 20-31.
22. Verstovsek, S., S. Lunin, H. Kantarjian, T. Manshouri, S. Faderl, J. Cortes, F. Giles, and M. Albitar. 2003. Clinical relevance of VEGF receptors 1 and 2 in patients with chronic myelogenous leukemia. Leuk. Res. 27: 661-669.
23. Cabanas, C., and F. Sanchez-Madrid. 1999. CD11b (leukocyte integrin CR3 α subunit). J. Biol. Regul. Homeostatic Agents 13: 130-133.
24. Asselin-Paturel, C., A. Boonstra, M. Dalod, I. Durand, N. Yessaad, C. Dezutter-Dambuyant, A. Vicari, A. O'Garra, C. Biron, F. Briere, and G. Trinchieri. 2001. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat. Immunol. 2: 1144-1150.
25. + mouse bone marrow progenitor cells restricted to macrophage differentiation that coexpress early B cell-associated genes. Exp. Hematol. 27: 1646-1654.
26. Lu, M., H. Kawamoto, Y. Katsube, T. Ikawa, and Y. Katsura. 2002. The common myelolymphoid progenitor: a key intermediate stage in hemopoiesis generating T and B cells. J. Immunol. 169: 3519-3525.
27. Melani, C., C. Chiodoni, G. Forni, and M. P. Colombo. 2003. Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity. Blood 102: 2138-2145.
28. Metcalf, D., N. A. Nicola, S. Mifsud, and L. Di Rago. 1999. Receptor clearance obscures the magnitude of granulocyte-macrophage colony-stimulating factor responses in mice to endotoxin or local infections. Blood 93: 1579-1585.
29. Young, D. C., and J. D. Griffin. 1986. Autocrine secretion of GM-CSF in acute myeloblastic leukemia. Blood 68: 1178-1181.
30. Lang, R. A., D. Metcalf, R. A. Cuthbertson, I. Lyons, E. Stanley, A. Kelso, G. Kannourakis, D. J. Williamson, G. K. Klintworth, T. J. Gonda, et al. 1987. Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage. Cell 51: 675-686.
31. Hattori, K., S. Dias, B. Heissig, N. R. Hackett, D. Lyden, M. Tateno, D. J. Hicklin, Z. Zhu, L. Witte, R. G. Crystal, et al. 2001. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J. Exp. Med. 193: 1005-1014.
32. Ma, Q., D. Jones, and T. A. Springer. 1999. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity 10: 463-471.
33. Puch, S., S. Armeanu, C. Kibler, K. R. Johnson, C. A. Muller, M. J. Wheelock, and G. Klein. 2001. N-cadherin is developmentally regulated and functionally involved in early hematopoietic cell differentiation. J. Cell Sci. 114: 1567-1577.
34. Rafii, S., S. Avecilla, S. Shmelkov, K. Shido, R. Tejada, M. A. Moore, B. Heissig, and K. Hattori. 2003. Angiogenic factors reconstitute hematopoiesis by recruiting stem cells from bone marrow microenvironment. Ann. NY Acad. Sci. 996: 49-60.
35. Zhu, Z., K. Hattori, H. Zhang, X. Jimenez, D. L. Ludwig, S. Dias, P. Russie, H. Koo, H. J. Kim, D. Lu, et al. 2003. Inhibition of human leukemia in an animal model with human antibodies directed against vascular endothelial growth factor receptor 2: correlation between antibody affinity and biological activity. Leukemia 17: 604-611.
36. Bigas, A., D. I. Martin, and L. A. Milner. 1998. Notch1 and Notch2 inhibit myeloid differentiation in response to different cytokines. Mol. Cell. Biol. 18: 2324-2333.
37. Jonsson, J. I., Z. Xiang, M. Pettersson, M. Lardelli, and G. Nilsson. 2001. Distinct and regulated expression of Notch receptors in hematopoietic lineages and during myeloid differentiation. Eur. J. Immunol. 31: 3240-3247.
38. Schroeder, T., H. Kohlhof, N. Rieber, and U. Just. 2003. Notch signaling induces multilineage myeloid differentiation and up-regulates PU. 1 expression. J. Immunol. 170: 5538-5548.
39. Ye, Q., J. H. Shieh, G. Morrone, and M. A. Moore. 2004. Expression of constitutively active Notch4 (Int-3) modulates myeloid proliferation and differentiation and promotes expansion of hematopoietic progenitors. Leukemia 18: 777-787.
40. Zon, L. I. 2001. Self-renewal versus differentiation, a job for the mighty morphogens. Nat. Immunol. 2: 142-143.
41. Gasson, J. C. 1991. Molecular physiology of granulocyte-macrophage colony-stimulating factor. Blood 77: 1131-1145.
42. Hou, R., O. Goloubeva, D. S. Neuberg, J. L. Strominger, and S. B. Wilson. 2003. Interleukin-12 and interleukin-2-induced invariant natural killer T-cell cytokine secretion and perform expression independent of T-cell receptor activation. Immunology 110: 30-37.
43. Zhang, H., Y. Li, H. Li, R. Bassi, X. Jimenez, L. Witte, P. Bohlen, D. Hicklin, and Z. Zhu. 2004. Inhibition of both the autocrine and the paracrine growth of human leukemia with a fully human antibody directed against vascular endothelial growth factor receptor 2. Leuk. Lymphoma 45: 1887-1897.
44. Burg, J., V. Krump-Konvalinkova, F. Bittinger, and C. J. Kirkpatrick. 2002. GM-CSF expression by human lung microvascular endothelial cells: in vitro and in vivo findings. Am. J. Physiol. Lung Cell. Mol. Physiol. 283: L460-467.
45. Hofer, M., A. Vacek, and L. Weiterova. 2005. Action of granulopoiesis-stimulating cytokines rhG-CSF, rhGM-CSF, and rmGM-CSF on murine haematopoietic progenitor cells for granulocytes and macrophages (GM-CFC). Physiol. Res. 54: 207-213.
46. Krishnaswamy, G., J. Kelley, L. Yerra, J. K. Smith, and D. S. Chi. 1999. Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. J. Interferon Cytokine Res. 19: 91-104.
47. Mangi, M. H., and A. C. Newland. 1999. Interleukin-3 in hematology and oncology: current state of knowledge and future directions. Cytokines Cell. Mol. Ther. 5: 87-95.
48. Mordvinov, V. A., and C. J. Sanderson. 2001. Regulation of IL-5 expression. Arch. Immunol. Ther. Exp. 49: 345-351.
49. Bhardwaj, G., B. Murdoch, D. Wu, D. P. Baker, K. P. Williams, K. Chadwick, L. E. Ling, F. N. Karanu, and M. Bhatia. 2001. Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation. Nat. Immunol. 2: 172-180.
50. Yamane, T., T. Kunisada, H. Tsukamoto, H. Yamazaki, H. Niwa, S. Takada, and S. I. Hayashi. 2001. Wnt signaling regulates hemopoiesis through stromal cells. J. Immunol. 167: 765-772.
51. Xin, X., S. Yang, G. Ingle, C. Zlot, L. Rangell, J. Kowalski, R. Schwall, N. Ferrara, and M. E. Gerritsen. 2001. Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo. Am. J. Pathol. 158: 1111-1120.
52. Gerritsen, M. E., J. E. Tomlinson, C. Zlot, M. Ziman, and S. Hwang. 2003. Using gene expression profiling to identify the molecular basis of the synergistic actions of hepatocyte growth factor and vascular endothelial growth factor in human endothelial cells. Br. J. Pharmacol 140: 595-610.
53. Miyazawa, K., P. C. Hendrie, C. Mantel, K. Wood, L. K. Ashman, and H. E. Broxmeyer. 1991. Comparative analysis of signaling pathways between mast cell growth factor (c-kit ligand) and granulocyte-macrophage colony-stimulating factor in a human factor-dependent myeloid cell line involves phosphorylation of Raf-1, GTPase-activating protein and mitogen-activated protein kinase. Exp. Hematol. 19: 1110-1123.
54. Piacibello, W., L. Fubini, F. Sanavio, M. F. Brizzi, A. Severino, L. Garetto, A. Stacchini, L. Pegoraro, and M. Aglietta. 1995. Effects of human FLT3 ligand on myeloid leukemia cell growth: heterogeneity in response and synergy with other hematopoietic growth factors. Blood 86: 4105-4114.
55. Lennartsson, J., R. Shivakrupa, and D. Linnekin. 2004. Synergistic growth of SCF and GM-CSF involves kinase-dependent and independent contributions from c-kit. J. Biol. Chem. 43: 44544-44553.
56. Lehtonen, A., S. Matikainen, M. Miettinen, and I. Julkunen. 2002. Granulocyte-Macrophage colony-stimulating factor (GM-CSF)-induced STAT5 activation and target-gene expression during human monocyte/macrophage differentiation. J. Leukocyte Biol. 71: 511-519.
57. Valdembri, D., G. Serini, A. Vacca, D. Ribatti, and F. Bussolino. 2002. In vivo activation of JAK2/STAT-3 pathway during angiogenesis induced by GM-CSF, FASEB J. 16: 225-227.
58. Ramalho-Santos, M., S. Yoon, Y. Matsuzaki, R. C. Mulligan, and D. A. Melton. 2002. "Stemness": transcriptional profiling of embryonic and adult stem cells. Science 298: 597-600.
59. Bruno, L., R. Hoffmann, F. McBlane, J. Brown, R. Gupta, C. Joshi, S. Pearson, T. Seidl, C. Heyworth, and T. Enver. 2004. Molecular signatures of self-renewal, differentiation, and lineage choice in multipotential hemopoietic progenitor cells in vitro. Mol. Cell. Biol. 24: 741-756.
60. Lund-Johansen, F., D. Houck, R. Hoffman, K. Davis, and J. Olweus. 1999. Primitive human hematopoietic progenitor cells express receptors for granulocyte-macrophage colony-stimulating factor. Exp. Hematol 27: 762-772.
61. Martinez-Moczygemba, M., and D. P. Huston. 2003. Biology of common β receptor-signaling cytokines: IL-3, IL-5, and GM-CSF. J. Allergy Clin. Immunol. 112: 653-665.
62. Young, M. R., M. Newby, and H. T. Wepsic. 1987. Hematopoiesis and suppressor bone marrow cells in mice bearing large metastatic Lewis lung carcinoma tumors. Cancer Res. 47: 100-105.
63. + myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation. J. Immunol. 165: 779-785.
64. + T cells. Blood 96: 3838-3846.
65. Kusmartsev, S., and D. I. Gabrilovich. 2002. Immature myeloid cells and cancer-associated immune suppression. Cancer Immunol. Immunother. 51: 293-298.
66. Bellamy, W. T., L. Richter, Y. Frutiger, and T. M. Grogan. 1999. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies. Cancer Res. 59: 728-733.
67. Fiedler, W., U. Graeven, S. Ergun, S. Verago, N. Kilic, M. Stockschlader, and D. K. Hossfeld. 1997. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia. Blood 89: 1870-1875.
68. Bellamy, W. T., L. Richter, D. Sirjani, C. Roxas, B. Glinsmann-Gibson, Y. Frutiger, T. M. Grogan, and A. F. List. 2001. Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodyspiastic syndromes. Blood 97: 1427-1434.
69. Litwin, C., K. G. Leong, R. Zapf, H. Sutherland, S. C. Naiman, and A. Karsan. 2002. Role of the microenvironment in promoting angiogenesis in acute myeioid leukemia. Am. J. Hematol. 70: 22-30.
70. Mesters, R. M., T. Padro, R. Bieker, M. Steins, M. Kreuter, M. Goner, S. Kelsey, P. Scigalla, W. Fiedler, T. Buchner, and W. E. Berdel. 2001. Stable remission after administration of the receptor tyrosine kinase inhibitor SU5416 in a patient with refractory acute myeloid leukemia. Blood 98: 241-243.
71. Dias, S., K. Hattori, B. Heissig, Z. Zhu, Y. Wu, L. Witte, D. J. Hicklin, M. Tateno, P. Bohlen, M. A. Moore, and S. Rafii. 2001. Inhibition of both paracrine and automne VEGF/VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias. Proc. Natl. Acad. Sci. USA 98: 10857-10862.
72. Larrivée, B., K. Niessen, I. Pollett, S. Y. Corbel, M. Long, F. M. Rossi, P. L. Olive, and A. Karsan. 2005. Minimal contribution of marrow-derived endothelial precursors to tumor vasculature. J. Immunol. 175: 2890-2899.